10-K/A

BIOTIME 10-K A 12-31-2010

Company: Lineage Cell Therapeutics, Inc.
Filed: July 6, 2011
Period of Report: December 31, 2010
Accession Number: 0001140361-11-035607

View Document ↗ View on SEC.gov ↗